Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives

Contraception

Volumn 73, Issue 1, 2006, Pages 41-45

  Sulak, Patricia J ^a,b   Buckley, Terry ^a   Kuehl, Thomas J ^a,b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Extended oral contraceptive regimens; Health care professionals; Prescribing habits

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; ATTITUDE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; FEMALE; GYNECOLOGY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; INSTRUMENTATION; MALE; MEDICAL PRACTICE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; NURSE; OBSTETRICS; ORAL CONTRACEPTION; PHYSICIAN ASSISTANT; PRESCRIPTION; PRIMARY MEDICAL CARE; UNITED STATES; WITHDRAWAL BLEEDING;

ATTITUDE OF HEALTH PERSONNEL; CONTRACEPTIVES, ORAL; FEMALE; GYNECOLOGY; HUMANS; MENSTRUAL CYCLE; NURSE PRACTITIONERS; OBSTETRICS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUESTIONNAIRES; TIME FACTORS;

EID: 29144470597     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.07.001     Document Type: Article

References (17)

1. P.J. Sulak, R.D. Scow, C. Preece, M.W. Riggs, and T.J. Kuehl Hormone withdrawal symptoms in oral contraceptive users Obstet Gynecol 95 2000 261 266
2. F.D. Anderson, and H. Hait A multicenter, randomized study of an extended cycle oral contraceptive Contraception 68 2003 89 96
3. M. Kwiecien, A. Edelman, M.D. Nichols, and J.T. Jensen Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial Contraception 67 2003 9 13
4. L. Miller, and J.P. Hughes Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial Obstet Gynecol 101 2003 653 661
5. L. Miller, and K.M. Notter Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial Obstet Gynecol 98 2001 771 778
6. P.J. Sulak, B.E. Cressman, E. Waldrop, S. Holleman, and T.J. Kuehl Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms Obstet Gynecol 89 1997 179 183
7. P.J. Sulak, T.J. Kuehl, M. Ortiz, and B.L. Shull Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms Am J Obstet Gynecol 186 2002 1142 1149
8. P.J. Sulak, J. Carl, I. Gopalakrishnan, A. Coffee, and T. Kuehl Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding Contraception 70 2004 281 287
9. I. den Tonkelaar, and B.J. Oddens Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone therapy use Contraception 59 1999 357 362
10. I. Wiegratz, H.H. Hommel, T. Zimmermann, and H. Kuhl Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives Contraception 69 2004 37 42
11. P. Vercellini, G. Frontino, O. De Giorgi, G. Pietropaolo, R. Pasin, and P. Crosignani Continuous use of an oral contraceptive for endometriosis- associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen Fertil Steril 80 2003 560 563
12. H. Sullivan, H. Furniss, J. Spona, and M. Elstein Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Fertil Steril 72 1999 115 120
13. W. Schlaff, A.M. Lynch, H.D. Hughes, M.I. Cedars, and D.L. Smith Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression Am J Obstet Gynecol 190 2004 943 951
14. J. Spona, M. Elstein, and W. Feichtinger Shorter pill-free interval in combined oral contraceptives decreases follicular development Contraception 54 1996 71 77
15. S.R. Killick, C. Fitzgerald, and A. Davis Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval Am J Obstet Gynecol 179 1998 S18 S24
16. V.L. Holt, K.L. Cushing-Haugen, and J.R. Daling Oral contraceptives, tubal sterilization, and functional ovarian cyst risk Obstet Gynecol 102 2003 252 258
17. G. Bachmann, P.J. Sulak, C. Sampson-Landers, N. Benda, and J. Marr Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone Contraception 70 2004 191 198